RESUMO
INTRODUCTION: Potentially serious drug interactions are often detected by pharmacists. In such cases fast communication with the General Practitioner (GP) is required. However, contacting physicians by telephone is often difficult. In a previous project a fax template was developed allowing fast communication of serious drug interactions to the GP. Utilization of the template and interactions detected were assessed in this observational study. METHODS: All pharmacists and GP in the city of Bremen were informed about the template. Severity of drug interactions was rated by the ABDA classification system (from 1 "contraindication" to 8: "no action recommended"). Participating pharmacists were asked to send an anonymized copy of every template. A descriptive analysis of the interactions, actions recommended by the pharmacists and physicians' reactions was performed. RESULTS: 123 faxes were sent to the Pharmacist's Association in Bremen by 23 pharmacies (1â-â25 fax/pharmacy). In 108/123 cases (severe) interactions were reported. In the remaining cases the interaction could not be verified (nâ=â7) or unintended double medication (nâ=â8) was detected. GP gave feedback in 69.4â% (nâ=â75). The GP followed the recommendations made by the pharmacist changing their original prescription, discontinuing medication and or monitoring patient´s therapy followed the recommendations made by the pharmacist (nâ=â23). Beside that GP, chose another strategy (nâ=â15) or gave feedback that the interaction was known and issued the prescription as planned (31.5â%, nâ=â34). Check back with the patient was rarely recommended (nâ=â3). DISCUSSION: Fax templates seem to be an accepted instrument by pharmacists reporting serious drug interactions and able to improve medication safety. Different than intended, pharmacists used template for reporting less severe drug interactions. Attention has to be paid to the risk of over alerting, reporting which can lead to unintended neglect of urgent problems. Pharmacists should therefore be encouraged to report only serious drug interactions.
Assuntos
Interações Medicamentosas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/prevenção & controle , Comunicação Interdisciplinar , Erros de Medicação/prevenção & controle , Farmácias , Médicos , HumanosRESUMO
In cardiac muscle, junctin forms a quaternary protein complex with the ryanodine receptor (RyR), calsequestrin, and triadin 1 at the luminal face of the junctional sarcoplasmic reticulum (jSR). By binding directly the RyR and calsequestrin, junctin may mediate the Ca(2+)-dependent regulatory interactions between both proteins. To gain more insight into the underlying mechanisms of impaired contractile relaxation in transgenic mice with cardiac-specific overexpression of junctin (TG), we studied cellular Ca(2+) handling in these mice. We found that the SR Ca(2+) load was reduced by 22% in cardiomyocytes from TG mice. Consistent with this, the frequency of Ca(2+) sparks was diminished by 32%. The decay of spontaneous Ca(2+) sparks was prolonged by 117% in TG. This finding was associated with a lower Na(+)-Ca(2+) exchanger (NCX) protein expression (by 67%) and a higher basal RyR phosphorylation at Ser(2809) (by 64%) in TG. The shortening- and Delta[Ca](i)-frequency relationships (0.5-4 Hz) were flat in TG compared to wild-type (WT) which exhibited a positive staircase for both parameters. Furthermore, increasing stimulation frequencies hastened the time of relaxation and the decay of [Ca](i) by a higher percentage in TG. We conclude that the impaired relaxation in TG may result from a reduced NCX expression and/or a higher SR Ca(2+) leak. The altered shortening-frequency relationship in TG seems to be a consequence of an impaired excitation-contraction coupling with depressed SR Ca(2+) release at higher rates of stimulation. Our data suggest that the more prominent frequency-dependent hastening of relaxation in TG results from a stimulation of SR Ca(2+) transport reflected by corresponding changes of [Ca](i).
Assuntos
Sinalização do Cálcio/fisiologia , Proteínas de Ligação ao Cálcio/metabolismo , Proteínas de Membrana/metabolismo , Oxigenases de Função Mista/metabolismo , Proteínas Musculares/metabolismo , Miócitos Cardíacos/metabolismo , Adaptação Fisiológica , Animais , Proteínas de Ligação ao Cálcio/química , Proteínas de Ligação ao Cálcio/genética , ATPases Transportadoras de Cálcio/metabolismo , Calsequestrina/metabolismo , Cães , Expressão Gênica , Técnicas In Vitro , Isoproterenol/farmacologia , Proteínas de Membrana/genética , Camundongos , Camundongos Transgênicos , Oxigenases de Função Mista/genética , Proteínas Musculares/genética , Relaxamento Muscular/fisiologia , Miócitos Cardíacos/efeitos dos fármacos , Fosforilação , Canal de Liberação de Cálcio do Receptor de Rianodina/química , Canal de Liberação de Cálcio do Receptor de Rianodina/metabolismo , Retículo Sarcoplasmático/metabolismo , ATPases Transportadoras de Cálcio do Retículo Sarcoplasmático , Trocador de Sódio e Cálcio/metabolismoRESUMO
OBJECTIVE: Protein phosphatase 1 (PP1) has been implicated in the control of cardiac function. Cardiac specific overexpression of the catalytic subunit, PP1c, results in hypertrophy and depressed contractility. METHODS: To further address the role of PP1, transgenic mice (TG) were generated that overexpress in heart a functional COOH-terminally truncated form (amino acids 1-140) of the PP1 inhibitor-2 (I-2(140)). RESULTS: The TG hearts show increased levels of I-2(140) mRNA as well as protein and activity. No increase in absolute or relative heart weight was observed, nor any changes in gross pathology or increase in morbidity or mortality in the TG mice. Immunohistochemical and biochemical analyses revealed that expression of the I-2(140) protein is confined to cardiomyocytes where it is mainly localized in the cytosol. The total protein phosphatase (PP) activity was reduced by 80% in TG hearts as compared to wild-type littermates (WT). The PP1c mRNA level was the same in TG and WT, while the protein level was increased by approximately 7-fold in TG animals. The maximal rates of contraction (+dP/dt) and of relaxation (-dP/dt) were increased by 32% and 40%, respectively, in the intact catheterized TG mice compared to WT. However, the maximal contractile response to beta-adrenergic agonists was comparable in hearts from TG and WT mice. In isolated cardiomyocytes of TG mice, Ca2+transient amplitude was increased by 50% under basal conditions and by 60% upon rapid caffeine application. The phospholamban (PLB) protein level was unchanged whereas the basal phosphorylation of PLB at Ser(16) was significantly increased in TG hearts. CONCLUSION: These results indicate that I-2(140) overexpression results in decreased PP1 activity and enhanced contractility in the heart, underscoring the fundamental role of PP1 in cardiac function.
Assuntos
Cardiomegalia/enzimologia , Contração Miocárdica/fisiologia , Miocárdio/enzimologia , Fosfoproteínas Fosfatases/metabolismo , Proteínas/genética , Animais , Northern Blotting/métodos , Cálcio/metabolismo , Canais de Cálcio/metabolismo , Engenharia Genética , Imuno-Histoquímica/métodos , Camundongos , Camundongos Transgênicos , Miocárdio/metabolismo , Perfusão , Fosfoproteínas Fosfatases/antagonistas & inibidores , Proteína Fosfatase 1 , Proteínas/metabolismo , Retículo Sarcoplasmático/metabolismoRESUMO
Reversible protein phosphorylation is an essential regulatory mechanism in many cellular functions. In contrast to protein kinases, the role and regulation of protein phosphatases has remained ambiguous. To address this issue, we generated transgenic mice that overexpress the catalytic subunit alpha of protein phosphatase 2A (PP2A) (PP2Acalpha) in the heart driven by the alpha-myosin heavy chain promoter. Overexpression of the PP2Acalpha gene in the heart led to increased levels of the transgene both at RNA and protein levels. This was accompanied by a significant increase of PP2A enzyme activity in the myocardium. Morphological analysis revealed isles of necrosis and fibrosis. The phosphorylation state of phospholamban, troponin inhibitor, and eukaryotic elongation factor 2 was reduced significantly. The expression of junctional (calsequestrin) and free SR proteins (SERCA and phospholamban) was not altered. Whereas no increase in morbidity or mortality was noted, transgenic mice developed cardiac hypertrophy and reduced contractility of the heart, as well as cardiac dilatation as shown by biplane echocardiography. Taken together, these findings are indicative of the fundamental role of PP2A in cardiac function and imply that disturbances in protein phosphatases expression and activity may cause or aggravate the course of cardiac diseases.
Assuntos
Coração/fisiologia , Fosfoproteínas Fosfatases/química , Actinas/genética , Animais , Northern Blotting , Western Blotting , Cálcio/metabolismo , Domínio Catalítico , Células Cultivadas , DNA Complementar/metabolismo , Dobutamina/farmacologia , Relação Dose-Resposta a Droga , Ecocardiografia , Fibrose , Cardiopatias/metabolismo , Processamento de Imagem Assistida por Computador , Imuno-Histoquímica , Camundongos , Camundongos Transgênicos , Miocárdio/metabolismo , Fosfoproteínas Fosfatases/metabolismo , Fosforilação , Regiões Promotoras Genéticas , Proteína Fosfatase 2 , RNA/metabolismo , Receptores Adrenérgicos beta/metabolismo , TransgenesRESUMO
OBJECTIVE: The aim of the present study was to assess the effects of A(1)-adenosine receptor (A1-AR) stimulation in ventricle of A(1)-adenosine receptor overexpressing mice (transgenic mice, TG). METHODS: Effects of the A(1)-adenosine receptor agonist R-PIA ((-)-N(6)-phenylisopropyladenosine) on phosphorylation of phospholamban (PLB), Ca(2+) transients, Ca(2+) currents and cell shortening were studied in isolated ventricular cardiomyocytes. RESULTS: R-PIA alone did not affect contractility in isolated electrically stimulated cardiomyocytes from wild-type mice (WT) or TG. However, after pre-stimulation of beta-adrenoceptors by isoproterenol, R-PIA reduced contractility in cardiomyocytes from WT but increased contractility in TG. Under the same conditions, R-PIA reduced isoproterenol-stimulated currents through L-type Ca(2+) channels, Ca(2+) transients and phosphorylation of PLB in cardiomyocytes from WT. In contrast, R-PIA diminished phospholamban phosphorylation induced by isoproterenol but augmented isoproterenol-elevated currents through L-type Ca(2+) channels, and isoproterenol-heightened Ca(2+) transients in cardiomyocytes from TG. CONCLUSIONS: We suggest that A(1)-adenosine receptor overexpression reverses the interaction of beta-adrenergic and A(1)-adenosine receptor stimulation, at least in part. Hence, the receptor/effector coupling is dependent on receptor density in this model.
Assuntos
Adenosina/análogos & derivados , Miócitos Cardíacos/metabolismo , Receptores Purinérgicos P1/genética , Transdução de Sinais , Adenosina/farmacologia , Animais , Cálcio/metabolismo , Canais de Cálcio/metabolismo , Proteínas de Ligação ao Cálcio/metabolismo , Cardiotônicos/farmacologia , Tamanho Celular/efeitos dos fármacos , Ventrículos do Coração , Isoproterenol/farmacologia , Camundongos , Camundongos Transgênicos , Miócitos Cardíacos/efeitos dos fármacos , Fosforilação , Ratos , Estimulação QuímicaRESUMO
OBJECTIVE: Junctin is a major transmembrane protein in cardiac junctional sarcoplasmic reticulum, which forms a quaternary complex with the ryanodine receptor (Ca(2+) release channel), triadin, and calsequestrin. METHODS: To better understand the role of junctin in excitation-contraction coupling in the heart, we generated transgenic mice with targeted overexpression of junctin to mouse heart, using the alpha-MHC promoter to drive protein expression. RESULTS: The protein was overexpressed 10-fold in mouse ventricles and overexpression was accompanied by cardiac hypertrophy (19%). The levels of two other junctional SR-proteins, the ryanodine receptor and triadin, were reduced by 32% and 23%, respectively. However, [3H]ryanodine binding and the expression levels of calsequestrin, phospholamban and SERCA2a remained unchanged. Cardiomyocytes from junctin-overexpressing mice exhibited impaired relaxation: Ca(2+) transients decayed at a slower rate and cell relengthening was prolonged. Isolated electrically stimulated papillary muscles from junctin-overexpressing hearts exhibited prolonged mechanical relaxation, and echocardiographic parameters of relaxation were prolonged in the living transgenic mice. The amplitude of caffeine-induced Ca(2+) transients was lower in cardiomyocytes from junctin-overexpressing mice. The inactivation kinetics of L-type Ca(2+) channel were prolonged in junctin-overexpressing cardiomyocytes using Ca(2+) or Ba(2+) as charge carriers. CONCLUSION: Our data provide evidence that cardiac-specific overexpression of junctin is accompanied by impaired myocardial relaxation with prolonged Ca(2+) transient kinetics on the cardiomyocyte level.